Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer-Reference-Cited by-同舟云学术

Success rate of microsatellite instability examination and complete response with pembrolizumab in biliary tract cancer

Published:2021-05-21 Issue:6 Volume:5 Page:712-716
ISSN:2397-9070
Container-title:JGH Open
language:en
Short-container-title:JGH Open

Author:

Kai Yugo¹,Ikezawa Kenji¹^ORCID,Takada Ryoji¹,Daiku Kazuma¹,Maeda Shingo¹,Abe Yutaro¹,Yamai Takuo¹,Fukutake Nobuyasu¹,Nakabori Tasuku¹,Uehara Hiroyuki¹,Nagata Shigenori²,Wada Hiroshi³,Ohkawa Kazuyoshi¹

Affiliation:

1. Department of Hepatobiliary and Pancreatic Oncology Osaka International Cancer Institute Osaka Japan

2. Department of Diagnostic Pathology and Cytology Osaka International Cancer Institute Osaka Japan

3. Department of Surgery Osaka International Cancer Institute Osaka Japan

Publisher

Wiley

Subject

Gastroenterology,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jgh3.12576

Reference25 articles.

1. Biliary tract cancer

2. Patients with recurrent biliary tract cancer have a better prognosis than those with unresectable disease: retrospective analysis of a multi-institutional experience with patients of advanced biliary tract cancer who received palliative chemotherapy

3. Comparative outcomes of elderly and non-elderly patients receiving first-line palliative chemotherapy for advanced biliary tract cancer

4. The impact of age and comorbidity in advanced or recurrent biliary tract cancer receiving palliative chemotherapy

5. Current and novel therapeutic opportunities for systemic therapy in biliary cancer

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunotherapeutic strategies in hepatopancreatobiliary cancers;Principles of Immunotherapy Breast and Gastrointestinal Cancers;2025

2. Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma;BMC Medicine;2024-01-29

3. Endoscopic ultrasound-guided tissue acquisition for comprehensive genomic profiling;Journal of Medical Ultrasonics;2024-01-28

4. A phase II study to evaluate the safety and efficacy of anlotinib combined with toripalimab for advanced biliary tract cancer;Clinical & Translational Immunology;2024-01

5. Comprehensive review of pancreatic acinar cell carcinoma: epidemiology, diagnosis, molecular features and treatment;Japanese Journal of Clinical Oncology;2023-12-18